METHOD FOR SCREENING ANTI-TUMOR AGENT

摘要

The present invention relates to: a method for screening an anti-tumor agent targeting a MET signaling pathway using a Wnt/β-catenin signaling pathway in a cancer cell caused by the damage of a MET signaling pathway; and a reactivity predicting kit of treatment candidate material for the cancer cell caused by the damage of the MET signaling pathway including a medicine to whether the Wnt/β-catenin signaling pathway is active or not. Using the method for screening or the kit of the invention allows to easily detect the treatment candidate material targeting the MET signaling pathway in the cancer cell caused by the damage of the MET signaling pathway so as to be able to be widely used in the development of the anti-cancer treating agent.